Palatin PTN Stock
Palatin Price Chart
Palatin PTN Financial and Trading Overview
| Palatin stock price | 1.79 USD |
| Previous Close | 2.15 USD |
| Open | 2.2 USD |
| Bid | 2.13 USD x 900 |
| Ask | 2.71 USD x 1000 |
| Day's Range | 2.2 - 2.3 USD |
| 52 Week Range | 2.08 - 9.5 USD |
| Volume | 32.76K USD |
| Avg. Volume | 63.28K USD |
| Market Cap | 25.7M USD |
| Beta (5Y Monthly) | 1.014084 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.98 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PTN Valuation Measures
| Enterprise Value | 5.94M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.252809 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 6.6530795 |
| Price/Book (mrq) | 2.5930233 |
| Enterprise Value/Revenue | 1.539 |
| Enterprise Value/EBITDA | -0.167 |
Trading Information
Palatin Stock Price History
| Beta (5Y Monthly) | 1.014084 |
| 52-Week Change | -72.12% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 9.5 USD |
| 52 Week Low | 2.08 USD |
| 50-Day Moving Average | 2.41 USD |
| 200-Day Moving Average | 3.74 USD |
PTN Share Statistics
| Avg. Volume (3 month) | 63.28K USD |
| Avg. Daily Volume (10-Days) | 41.7K USD |
| Shares Outstanding | 11.52M |
| Float | 11.28M |
| Short Ratio | 5.08 |
| % Held by Insiders | 3.07% |
| % Held by Institutions | 15.88% |
| Shares Short | 320.65K |
| Short % of Float | 2.82% |
| Short % of Shares Outstanding | 2.77% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -926.066% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -64.40% |
| Return on Equity (ttm) | -157.094% |
Income Statement
| Revenue (ttm) | 3.86M USD |
| Revenue Per Share (ttm) | 0.37 USD |
| Quarterly Revenue Growth (yoy) | 453.30% |
| Gross Profit (ttm) | -20076506 USD |
| EBITDA | -35519496 USD |
| Net Income Avi to Common (ttm) | -29595042 USD |
| Diluted EPS (ttm) | -2.77 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 19.63M USD |
| Total Cash Per Share (mrq) | 1.7 USD |
| Total Debt (mrq) | 799.8K USD |
| Total Debt/Equity (mrq) | 8.34 USD |
| Current Ratio (mrq) | 2.045 |
| Book Value Per Share (mrq) | 0.86 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -26532084 USD |
| Levered Free Cash Flow (ttm) | -20787306 USD |
Profile of Palatin
| Country | United States |
| State | NJ |
| City | Cranbury |
| Address | Cedar Brook Corporate Center |
| ZIP | 08512 |
| Phone | 609 495 2200 |
| Website | https://palatin.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 33 |
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL3994, a peptide mimetic molecule with amino acid mimetic structure and amino acids properties; and L8177, an oral peptide formulation for treatment of ulcerative colitis, which entered Phase 2 clinical trials. The company was founded in 1986 and is based in Cranbury, New Jersey.
Q&A For Palatin Stock
What is a current PTN stock price?
Palatin PTN stock price today per share is 1.79 USD.
How to purchase Palatin stock?
You can buy PTN shares on the NYSE American exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Palatin?
The stock symbol or ticker of Palatin is PTN.
Which industry does the Palatin company belong to?
The Palatin industry is Biotechnology.
How many shares does Palatin have in circulation?
The max supply of Palatin shares is 17.31M.
What is Palatin Price to Earnings Ratio (PE Ratio)?
Palatin PE Ratio is now.
What was Palatin earnings per share over the trailing 12 months (TTM)?
Palatin EPS is -2.98 USD over the trailing 12 months.
Which sector does the Palatin company belong to?
The Palatin sector is Healthcare.
Palatin PTN included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NYSE AMEX COMPOSITE INDEX XAX | 4890.31 USD — |
-1.43
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}